Platelet genetic testing by next-generation sequencing: A practical update

Inherited platelet disorders (IPDs) are a heterogeneous group of disorders characterized by normal or reduced platelet counts, bleeding diatheses of varying severities, and the presence (syndromic) or absence (non-syndromic) of involvement of other organs. Due to the lack of highly specific platelet function tests and overlapping clinical and laboratory features, diagnosing the underlying cause of IPDs remains challenging. In recent years, genetic testing via next-generation sequencing (NGS) technologies to rapidly analyze multiple genes has gradually emerged as an important part of the laboratory investigation of patients with IPDs. A systemic clinical and laboratory testing approach and thorough phenotype and genotype correlation studies of both patients and their family members are crucial for accurate diagnoses of IPDs.

Automated summary

Inherited platelet disorders (IPDs) are a diverse group of disorders with normal or reduced platelet counts, varying severities of bleeding tendencies, and involvement or non-involvement of other organs. Diagnosing the underlying cause of IPDs is challenging due to the lack of highly specific platelet function tests and overlapping clinical and laboratory features. Genetic testing through next-generation sequencing (NGS) technologies has become an important part of the laboratory investigation for patients with IPDs, along with thorough clinical and laboratory testing and phenotype and genotype correlation studies.